Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-29

Clinical Trial Update: Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing spinal morphine at 0.2–0.3 mg with intrathecal bupivacaine at 0.25% or 0.5% for femoral nerve block after total knee arthropl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (intrathecal) (bupivacaine hydrochloride)
  • Morphine (spinal) (morphine)

Snippet

Sponsor: Mahidol University | Conditions: Post Operative Pain, Total Knee Replacement | Phase 4 | Status: COMPLETED